Brochure
18 Oct 2024
3P Biopharmaceuticals and Biovian join forces to create 3PBIOVIAN, a leading pa
PDF 239 kB
Biovian and 3P Biopharmaceuticals (“3P”), two leading biologics Contract Development and Manufacturing Organizations (CDMOs), announced their combination.
Content provided by our supplier
3PBIOVIAN
-
ES -
2015On CPHI since
-
3Certificates
-
250 - 499Employees
Company types
Primary activities
Other Content from 3PBIOVIAN (1)
-
News Rokote Laboratories signs an agreement with 3PBIOVIAN for GMP manufacturing of adenovirus vector-based COVID-19 vaccine
Rokote Laboratories Finland Ltd. has selected 3PBIOVIAN as their CDMO partner for GMP manufacturing of adenovirus type 5 (Ad5) vector-based candidate expressing a modified spike protein of severe acute respiratory coronavirus 2 (SARS-CoV-2).
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance